Cardiothoracic & vascular anesthesia

Milrinone versus Dobutamine as Supportive Agent for Right Ventricular Dysfunction after Cardiopulmonary Bypass: A Randomized Comparative Study

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Primary result · TAPSE at 24 hours (adjusted for baseline TAPSE and LVEF)Result — go to the resultAdjusted difference 1.82 mm 95% CI 0.72–2.92

Authors' conclusion

Milrinone and dobutamine provide comparable overall RV recovery, though milrinone was associated with modestly higher adjusted TAPSE at 24 hours of uncertain clinical significance and increased norepinephrine requirements.

Study context

Population
Adults with new right ventricular (RV) systolic dysfunction (TAPSE ≤17 mm) after cardiopulmonary bypass (CPB), tertiary cardiac surgery center
Participants
88 adults
Comparison
Milrinone vs dobutamine
Primary endpoint
Co-primary: duration of mechanical ventilation and change in TAPSE
Follow-up
24 hours
Methodological detailsopen-label, parallel-group, single-centre
  • Open-label
  • Parallel-group
  • Single-centre

Primary result

As reported in the abstract

TAPSE at 24 hours (adjusted for baseline TAPSE and LVEF)

Adjusted difference

1.82 mm

95% CI 0.72–2.92

P = 0.001

Milrinone vs Dobutamine
adjusted difference 1.82 mm (95% CI 0.72–2.92); P = 0.001
TAPSE improved significantly over 24 hours in both groups
P < 0.001

Secondary outcomes

TAPSE improvement, subgroup pulmonary artery systolic pressure (PASP) >40 mmHg (n = 30; exploratory) · 1, 6 and 24 hours

Greater TAPSE improvement with milrinone at each time point
P < 0.05
  • Interaction p = 0.010
  • Exploratory subgroup analysis

TAPSE, subgroup PASP ≤40 mmHg (n = 58)

Drugs equivalent

Safety

Norepinephrine requirement

P = 0.021

Norepinephrine requirement, subgroup PASP >40 mmHg

P = 0.586

Original publication

Milrinone versus Dobutamine as Supportive Agent for Right Ventricular Dysfunction after Cardiopulmonary Bypass: A Randomized Comparative Study. J Cardiothorac Vasc Anesth. Published 7 July 2026. doi:10.1053/j.jvca.2026.07.015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.